N/A N=224 Randomized Single-blind Other

Breast Cancer: Feasibility of an Educational Intervention

Women's Health: Neoplasm of Breast

Bottom Line

View on ClinicalTrials.gov: NCT04396665 ↗

Enrolled (actual)

224

Serious AEs

—

Results posted

Aug 2021

Primary outcome: Primary: Feasibility of an Educational Intervention: Adherence to the Intervention — 99; 83 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Precam (Behavioral)
Age: Adult · 25+ yrs
Sex: Female
Sponsor: University of Oviedo
Primary completion: Jan 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility of an Educational Intervention: Adherence to the Intervention	99; 83	—
PRIMARY Feasibility of an Educational Intervention: Drop Out After the Intervention Period	35; 7	—
PRIMARY Number of Diet and Activity Recommendations	9.38; 8.28	—
PRIMARY Breast Cancer Awareness	2.04; 1.31; 3.61; 3.38	—

Summary

Aim: To evaluate the viability of an educational intervention for the prevention of breast cancer risk and the modification of their risk behaviors through the use of a web application in women living in the Principality of Asturias. Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. Informed consent signed. Variables: personal characteristics (age, status, educational level, occupation), MIC index, dietary characteristics, level of physical activity, presence of known risks of breast cancer (number of children, breastfeeding, oral contraceptives, family history of cancer, previous cancer, breast density and knowledge related with breast cancer prevention. Intervention: * Intervention Group:6 months intervention using a web-app related with personal care and breast cancer risks, diet and physical activity. * Control Group: no intervention.

Eligibility Criteria

Inclusion Criteria

Informed consent signed
Capability to use internet

Exclusion Criteria

Breast cancer diagnosis duting the intervention

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04396665). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.